A case of malignant transformation of equine immune-mediated keratitis to B-cell lymphoma

被引:2
|
作者
Lisankis, Anthony P. [1 ]
Beavis, Brittany B. [2 ]
Weigt, Anne K. [1 ]
Nunnery, Catherine [3 ]
机构
[1] Eye Care Anim, Annapolis, MD 21401 USA
[2] US Army Med Res Inst Infect Dis, Ft Detrick, MD USA
[3] Equine Vet Vis, The Plains, VA USA
关键词
horse; B-cell lymphoma; equine herpesvirus 5; immune-mediated keratitis; neoplastic transformation; HERPESVIRUS TYPE-2 EHV-2; HORSES; INFLAMMATION;
D O I
10.1111/eve.13725
中图分类号
S85 [动物医学(兽医学)];
学科分类号
0906 ;
摘要
A 13-year-old Thoroughbred/Oldenburg gelding presented as a tertiary referral for a 6-year history of immune-mediated keratitis (IMMK) after the development of corneal and limbal nodules in the presence of medical therapy. A keratectomy extending to the limbus was performed to remove the affected cornea and limbal nodules. Two corneal-limbal samples were submitted for histopathology and initially diagnosed as marked lympho-histiocytic stromal keratitis with epithelial hyperplasia, keratinisation and keratinocyte apoptosis consistent with IMMK. Additional testing with immunohistochemical staining for CD3, CD20, PAX5 and IBA1 revealed large, atypical B-lymphocytes on a background of histiocytes and mature T-lymphocytes, with concern for T-cell-rich large B-cell lymphoma. PCR antigen receptor rearrangement clonality testing was also performed and was diagnostic for large B-cell lymphoma. Polymerase chain reaction (PCR) for equine herpesvirus 5 (EHV-5) was positive. Following keratectomy, a short course of neomycin/polymyxin B/dexamethasone ophthalmic ointment was prescribed; no other treatment nor adjunct therapy was performed. Eighteen months post-operation, the case remains visual and comfortable on no medications.
引用
收藏
页码:e346 / e351
页数:6
相关论文
共 50 条
  • [41] Contiguous Meningioma and B-Cell Lymphoma: A Scoping Review and Case Illustration
    Hicks, William H.
    Pernik, Mark N.
    Adeyemo, Emmanuel
    Mathews, John
    Pildain, Alex J.
    Payne, Russell
    WORLD NEUROSURGERY, 2022, 158 : 132 - 138
  • [42] Effects of B-Cell Lymphoma on the Immune System and Immune Recovery after Treatment: The Paradigm of Targeted Therapy
    Mancuso, Salvatrice
    Mattana, Marta
    Carlisi, Melania
    Santoro, Marco
    Siragusa, Sergio
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2022, 23 (06)
  • [43] Lenalidomide for the treatment of B-cell lymphoma
    Garciaz, Sylvain
    Coso, Diane
    de Colella, Jean-Marc Schiano
    Bouabdallah, Reda
    EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2016, 25 (09) : 1103 - 1116
  • [44] Lenalidomidefor the treatment of B-cell lymphoma
    Lubanski, Philip M.
    Czuczman, Myron S.
    EXPERT OPINION ON ORPHAN DRUGS, 2013, 1 (08): : 651 - 659
  • [45] Primary mediastinal B-cell lymphoma
    Alev Brown
    Tomoko Tagawa
    Current Respiratory Care Reports, 2014, 3 (4): : 187 - 191
  • [46] Tissue Eosinophilia in B-cell Lymphoma
    Zhou, Ting
    Wang, Hao Wei
    Ng, Siok Bian
    Summers, Thomas
    Xi, Liqiang
    Raffeld, Mark
    Pittaluga, Stefania
    Jaffe, Elaine S.
    AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 2024, 48 (04) : 426 - 436
  • [47] PLDLA/TPU Matrix Enriched with Cyclosporine A as a Therapeutic Platform for Immune-Mediated Keratitis (IMMK) in Horses
    Padjasek, Martyna
    Cislo-Sankowska, Anna
    Lis-Bartos, Anna
    Qasem, Badr
    Marycz, Krzysztof
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2023, 24 (06)
  • [48] MicroRNAs as Biomarkers of B-cell Lymphoma
    Sole, Carla
    Arnaiz, Esther
    Lawrie, Charles H.
    BIOMARKER INSIGHTS, 2018, 13
  • [49] Primary mediastinal B-cell lymphoma
    Brown, Alev
    Tagawa, Tomoko
    CURRENT PULMONOLOGY REPORTS, 2014, 3 (04) : 187 - 191
  • [50] A Rare Case of Primary Vulvar Diffuse Large B-Cell Lymphoma: A Case Report
    Singh, M.
    Ngakhusi, S.
    Shrestha, A.
    Subedi, P.
    Khadka, K.
    Dhakal, H. P.
    CLINICAL CASE REPORTS, 2024, 12 (12):